A detailed history of Hm Payson & CO transactions in Haleon PLC stock. As of the latest transaction made, Hm Payson & CO holds 1,810 shares of HLN stock, worth $17,557. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,810
Previous 1,810 -0.0%
Holding current value
$17,557
Previous $14,000 35.71%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$7.78 - $8.62 $3,501 - $3,878
-450 Reduced 19.91%
1,810 $14,000
Q3 2023

Nov 06, 2023

BUY
$7.85 - $8.94 $3,454 - $3,933
440 Added 24.18%
2,260 $18,000
Q2 2023

Jul 17, 2023

SELL
$8.04 - $9.0 $6,431 - $7,200
-800 Reduced 30.53%
1,820 $15,000
Q1 2023

Apr 18, 2023

SELL
$7.57 - $8.37 $1,642 - $1,816
-217 Reduced 7.65%
2,620 $21,000
Q4 2022

Feb 06, 2023

SELL
$5.96 - $8.06 $3,725 - $5,037
-625 Reduced 18.05%
2,837 $22,000
Q3 2022

Oct 25, 2022

BUY
$5.63 - $7.5 $19,491 - $25,965
3,462 New
3,462 $21,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Hm Payson & CO Portfolio

Follow Hm Payson & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.